Showing results (891-900 of 1,376) with videos related to

Sort By:
Pageof 138
Drug Development Research|March 21, 2014
The effect of mild to moderate renal impairment on the pharmacokinetics of the nucleoside analog hepatitis C virus polymerase inhibitor mericitabineJoshua Haznedar, Sebastian Moreira, Thomas Marbury, et al.
Drug Development Research|July 18, 2019
Dose-dependent chemopreventive effects of citronellol in DMBA-induced breast cancer among ratsJayaganesh Rajendran, Pugalendhi Pachaiappan, Suganthi Subramaniyan
Drug Development Research|July 18, 2019
The protective effect of syringic acid on dextran sulfate sodium-induced experimental colitis in BALB/c miceWenhui Fang, Shihong Zhu, Zhongbao Niu, et al.
Drug Development Research|July 14, 2019
Novel steroid sulfatase inhibitors based on N-thiophosphorylated 3-(4-aminophenyl)-coumarin-7-O-sulfamatesMateusz Daśko, Sebastian Demkowicz, Karol Biernacki, et al.
Drug Development Research|March 28, 2019
Glycitein induces reactive oxygen species-dependent apoptosis and G0/G1 cell cycle arrest through the MAPK/STAT3/NF-κB pathway in human gastric cancer cellsYan-Qing Zang, Yan-Yu Feng, Ying-Hua Luo, et al.
Drug Development Research|May 16, 2014
Peripheral synergism between tramadol and ibuprofen in the formalin testDaniel Chavarria-Bolaños, José Perez-Urizar, Christian Grandfils, et al.
Drug Development Research|June 4, 2014
A synthetic biotinylated peptide, BP21, inhibits the induction of mRNA expression of inflammatory substances by oxidized- and lyso-phosphatidylcholineAkira Sato, Takeshi Kumagai, Keiichi Ebina
Drug Development Research|January 27, 2015
Dalbergia odorifera Extract Ameliorates UVB-Induced Wrinkle Formation by Modulating Expression of Extracellular Matrix ProteinsSun Ah Ham, Eun Sil Kang, Taesik Yoo, et al.
Drug Development Research|September 11, 2012
Structure Activity Relationships for Derivatives of Adenosine-5'-Triphosphate as Agonists at P(2) Purinoceptors: Heterogeneity Within P(2X) and P(2Y) SubtypesGeoffrey Burnstock, Bilha Fischer, Charles H V Hoyle, et al.
Drug Development Research|July 29, 2022
Knockdown of replication protein A 3 induces protective autophagy and enhances cisplatin sensitivity in lung adenocarcinoma by inhibiting AKT/mTOR signaling via binding to cyclin-dependent kinases regulatory subunit 2Lijun Chen, Ke Hu, Yu Liu, et al.
Pageof 138